We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$39.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.48B
Cap. Flow %
6.28%
Top 10 Hldgs %
5.86%
Holding
3,447
New
176
Increased
1,376
Reduced
1,602
Closed
253

Sector Composition

Rank Sector Weight
1 Financials 10.78%
2 Consumer Discretionary 10.44%
3 Technology 10.24%
4 Industrials 10.05%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CQB
2951
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
$140K ﹤0.01%
12,949
+2,320
+22% +$25.8K
WSBF icon
2952
Waterstone Financial
WSBF
$376M
$139K ﹤0.01%
+12,177
New +$131K
VIRX
2953
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$139K ﹤0.01%
101
-10
-9% -$11.6K
ZIXI
2954
DELISTED
Zix Corporation
ZIXI
$139K ﹤0.01%
40,433
-2,614
-6% -$9.18K
WWE
2955
DELISTED
World Wrestling Entertainment
WWE
$138K ﹤0.01%
11,527
-40,138
-78% -$660K
BONT
2956
DELISTED
Bon-Ton Stores Inc/The
BONT
$137K ﹤0.01%
13,244
-2,299
-15% -$24.5K
GFA
2957
DELISTED
Gafisa S.A.
GFA
$137K ﹤0.01%
3,332
-447
-12% -$19.1K
CERS icon
2958
Cerus
CERS
$445M
$136K ﹤0.01%
32,809
-2,211
-6% -$9.47K
LIOX
2959
DELISTED
Lionbridge Technologies
LIOX
$136K ﹤0.01%
22,779
-7,203
-24% -$42.2K
ALR
2960
DELISTED
AlerisLife Inc
ALR
$135K ﹤0.01%
2,689
-222
-8% -$11K
DXLG icon
2961
Destination XL Group
DXLG
$31.7M
$133K ﹤0.01%
24,043
-1,995
-8% -$10.6K
TLPH icon
2962
Talphera
TLPH
$68M
$133K ﹤0.01%
650
-64
-9% -$12.8K
UCTT
2963
Ultra Clean Holdings
UCTT
$3.94B
$133K ﹤0.01%
14,674
-820
-5% -$7.84K
LYTS icon
2964
LSI Industries
LYTS
$887M
$132K ﹤0.01%
16,491
-99
-0.6% -$780
PMCS
2965
DELISTED
P M C SIERRA INC
PMCS
$130K ﹤0.01%
17,083
-6,720
-28% -$48.6K
DSCI
2966
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$129K ﹤0.01%
11,145
-678
-6% -$6.96K
EGY icon
2967
Vaalco Energy
EGY
$562M
$126K ﹤0.01%
17,489
-3,379
-16% -$25.6K
PIKE
2968
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
$126K ﹤0.01%
+14,168
New +$132K
NWBO
2969
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$126K ﹤0.01%
18,877
+4,951
+36% +$31.5K
HTBK
2970
DELISTED
Heritage Commerce
HTBK
$124K ﹤0.01%
15,105
-1,341
-8% -$10.9K
LGTY
2971
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$124K ﹤0.01%
12,600
-1,066
-8% -$10.3K
SNBC
2972
DELISTED
Sun Bancorp Inc
SNBC
$124K ﹤0.01%
6,198
-552
-8% -$10.6K
GSAT icon
2973
Globalstar
GSAT
$10.9B
$123K ﹤0.01%
+1,929
New +$98.9K
ZGNX
2974
DELISTED
Zogenix, Inc.
ZGNX
$123K ﹤0.01%
7,665
-199
-3% -$3.59K
SUPN icon
2975
Supernus Pharmaceuticals
SUPN
$2.74B
$122K ﹤0.01%
11,187
-249
-2% -$2.22K

Similar funds

Guggenheim Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Guggenheim Capital held 3,447 positions worth $39.5B, up 12% from $35.2B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Guggenheim Capital deployed $2.48B of net new capital in Q2 2014, opening 176 new positions and adding to 1,376 existing holdings. Its largest new stake was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $95.8M trimmed.

  • Guggenheim Capital's largest Q2 2014 buy was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.
  • Guggenheim Capital added most to Stanley Black & Decker in Q2 2014, an estimated $62.1M increase.
  • Guggenheim Capital's biggest Q2 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $95.8M.
  • Guggenheim Capital fully exited LSI CORPORATION in Q2 2014, selling an estimated $44.6M.
  • Guggenheim Capital's ten largest holdings make up 5.9% of its $39.5B portfolio in Q2 2014.
  • Guggenheim Capital opened 176 new positions and closed 253 in Q2 2014.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $39.5B.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.